The largest database of trusted experimental protocols

Phospho p38 antibody

Manufactured by Cell Signaling Technology
Sourced in United States

The Phospho-p38 antibody is a tool for detecting and quantifying the phosphorylated form of the p38 protein, a key component of the p38 mitogen-activated protein kinase (MAPK) signaling pathway. This antibody specifically recognizes the phosphorylated form of p38, which is an important indicator of pathway activation.

Automatically generated - may contain errors

8 protocols using phospho p38 antibody

1

Generation of IGPR-1 Antibodies and shRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rabbit polyclonal anti-IGPR-1 antibody was made against a peptide derived from the cytoplasmic domain of IGPR-129 (link)and anti-phospho-Ser220-IGPR-1 antibodies were previously described.30 (link) Phospho-p38 antibody was purchased from Cell Signaling. Secondary HRP-conjugated rabbit and mouse antibodies were purchased from Santa Cruz. Human lentiviral IGPR-1 shRNAs cloned into pGIPZ vector (clone; V2LHS_19029), 3′-TGGTCTAGGAGAGACCCTG-5′ and clone (V2LHS_19033) 3′-TTTGCTGGCAGCTGCGGCG-5′ were purchased from Dharmacon (Lafayette, CO, USA).
+ Open protocol
+ Expand
2

Protein Expression Analysis in Prefrontal Cortex

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein concentration of cells and the prefrontal cortex were determined using a BCA protein assay kit (Pierce Biotechnology, Inc.). A quantity of 20–40 μg of total proteins was loaded onto a 10–12 % gradient polyacrylamide gel, electrophoretically transferred to a polyvinylidene difluoride membrane, and probed with the following primary antibodies: TNF-α (1:1000, Santa Cruz), IL-1β (1:1000, Santa Cruz), phospho-NF-κB p65(S536) antibody (1:500, Cell Signaling Tech. MA, USA), NF-κB (1:1000, Cell Signaling), phospho-p38 antibody (1:1000, Cell Signaling), p38 antibody (1:1000, Cell Signaling), phospho-JNK antibody (1:1000, Santa Cruz Biotechnology, CA, USA), JNK antibody (1:1000, Santa Cruz Biotechnology), phospho-extracellular signal-regulated kinase (ERK)1/2 (1:2000, Cell Signaling), ERK1/2 (1:2000; Cell Signaling), OTR (1:2000, Abcam), inducible nitric oxide synthase (iNOS) (1:500, Cell Signaling), cyclooxygenase-2 (COX-2, 1:1000, Proteintech Group, Inc., CA, USA). β-actin (1:2000; Sigma-Aldrich) was used as an internal control. Secondary antibodies were horseradish peroxidase conjugated to goat/mouse anti-rabbit IgG (1:8000, Sigma-Aldrich). The membranes were developed using an enhanced chemiluminescence detection system (Pierce, Rockford, IL).
+ Open protocol
+ Expand
3

Rat Hindpaw Fibroblast Signaling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat hindpaw flexor tendon fibroblasts were seeded at 300,000 cells per well of a 6 well plate (Nunc, Thermo scientific, USA), in DMEM supplemented with 10% (v/v) FBS, 0.1 mM non-essential amino acids, 2 mM glutamax (Life Technologies, USA) and 100U penicillin/100 µg streptomycin (Life Technologies, USA). After one day the cells were serum starved in DMEM supplemented with 0.1 mM non essential amino acids (Life Technologies, USA), 2 mM glutamax and 100 U penicillin/100 µg streptomycin. The cells were then treated with Adaprev or 600 mM G6P for 5, 10, 15, 30 and 60 minutes with untreated cells as a control. All treatments were performed in triplicate. After treatment the cells were lysed in lysis buffer (Urea [8M], (Life Technologies, USA); Thiourea [1M], (Sigma-Aldrich, UK), CHAPS [4% w/v] (Sigma-Aldrich, UK), Dithiothreitol [65 mM], (MP Biomedical, USA) Protease Inhibitor [0.5% w/v] (Roche, Swtizerland); Phosphatase Inhibitor 1 [1% w/v], (Sigma-Aldrich, UK) Phosphatase Inhibitor 2 [1% w/v], (Sigma-Aldrich, UK)). Samples were then subjected to gel electrophoresis, transferred onto nitrocellulose and immunoblotted with a phospho-p38 antibody (Cell signalling technologies, USA).
+ Open protocol
+ Expand
4

Western Blot Analysis of Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
BPH-1 cells were lysed using Pro-prep TM protein extraction solution (iNtRON). Lysates were mixed with SDS-PAGE sample buffer and boiled at 100°C for 5 min. Equal amounts of protein samples were run on 10% SDS-PAGE gel and transferred onto PVDF membranes, which were incubated with the following primary antibodies (all at 1:1,000) overnight at 4°C: phospho-p38 antibody, phospho-JNK antibody, phospho-ERK antibody, anti-TLR4 antibody, phospho-STAT3 antibody (all from Cell Signaling, Beverly, Massachusetts, USA); also phospho-JAK2 antibody, phospho-NF-κB antibody, β-actin antibody (all from Abcam). After 3 washes with Tween 20-Tris buffered saline (T-TBS, Biosesang, Seongnam, Korea), proteins were probed with anti-rabbit HRP-conjugated secondary antibody 1:10,000 (Abcam). Proteins were visualized by enhanced chemiluminescence (ECL) using a ChemiDoc MP detection system (Bio-Rad, Hercules, California, USA).
+ Open protocol
+ Expand
5

ER-negative Breast Cancer Cell Line Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
ER-negative breast cancer cell lines MDA-MB-231, SKBR3, BT-474, and T47D were obtained from the American Type Culture Collection (Manassas, VA, USA). Recombinant adenoviruses, ad-mgp96 expressing mgp96, and control adenoviruses ad-pDC312 were created by our lab. The ER-α36-knockdown cell line, MDA-MB-231-ER-α36i, and MDA-MB-231-mock cell line, the ER-α36-negative breast cancer cell line MCF7-10A, ER-α36 antibody, E2β and BSA-E2β were generous gifts from Beijing Shenogen Biomedical Co. Ltd. Gp96 polyclonal antibody and Protein G were purchased from Santa Cruz Biotechnology (Dallas, Texas, USA). The gp96 monoclonal antibody (mAb) was generated in our lab. ERK antibody, Phospho-ERK antibody, p38 antibody, and Phospho-p38 antibody were purchased from Cell Signaling Technology (Danvers, Massachusetts, USA). The remaining antibodies were obtained from Zhongshan Goldenbridge Biotechnology (Beijing, China). Cycloheximide (CHX) and MG132 were from Beyotime Institute of Biotechnology (Shanghai, China). Glutathione Sepharose 4B was from GE Healthcare Life Sciences (Little Chalfont, Buckinghamshire, United Kingdom). The protein cross-linkers DTSSP and BS3 were purchased from Thermo Scientific (Waltham, Massachusetts, USA).
+ Open protocol
+ Expand
6

Immunomodulatory Effects of Beta-Glucans

Check if the same lab product or an alternative is used in the 5 most similar protocols
DMEM, fetal bovine serum (FBS) (Gibco/invitrogen, Carlsbad, CA, USA), a Cell Counting Kit-8 assay (Dojindo Lab, Kumamoto, Japan), β-glucan kit (Megazyme International, Wicklow, Ireland), Phagocytosis Assay Kit (Cayman, MI, USA), cyclophosphamide (Sigma Aldrich, St.Louis, MO, USA) β-1,3-glucan (Sigma Aldrich, St.Louis, MO, USA) and cordycepin (Sigma Aldrich, St.Louis, MO, USA) were purchased. Phospho-Lyn antibody, Lyn antibody, phospho-Syk antibody, Syk antibody, phospho-ERK antibody, ERK antibody, phospho-p38 antibody, p38 antibody, phospho-JNK antibody, JNK antibody, NFκB antibody, phospho-IκB antibody and IκB antibody were obtained from Cell signaling Technology Inc. (Danvers, MA, USA). β-Actin antibody was obtained from Santa Cruz (Dallas, TX, USA).
+ Open protocol
+ Expand
7

Quantitative RT-PCR and Western Blot Analysis of Tracheal Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from whole tracheas using the Direct-zol RNA MiniPrep Kit (Zymo Research). cDNA was synthesized using the iScript cDNA Synthesis Kit (Bio-Rad), and quantitative RT-PCR was performed with iQ SYBR Green Supermix (Bio-Rad) using a StepOne Plus system (Applied Biosystems). For primer sequences see Table S2.
Western blot analysis was performed on protein extracts from total trachea, epithelium and mesenchyme. Equal amounts of protein were separated by SDS-PAGE and transferred onto polyvinylidene fluoride membranes. Membranes were blocked for 1 h with 5% (w/v) dried milk in PBS containing 0.1% Tween 20, and incubated with phospho-Smad1/5/8 antibody (1:1000; Cell Signaling, 9511), phospho-p38 antibody (1:2000; Cell Signaling, 4511), phospho-SAPK/JNK (Thr183/Tyr185) (G9) antibody (1:1000; Cell Signaling, 9255) and β-actin antibody (1:3000; Abcam, ab8226) in blocking buffer overnight at 4°C, followed by HRP-conjugated secondary antibody (Bio-Rad). Proteins were visualized using the ECL detection system (FEMTOMAX-110, Rockland Immunochemicals). The phospho-Smad1/5/8 band was validated by a positive control (HMEC1 cell treated with Bmp9) and phospho-p38 and phospho-Jun bands by molecular weight.
+ Open protocol
+ Expand
8

Analysis of Inflammatory Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
MACS-purified CD4+CD25+ T cells were stimulated with TNF (100 ng/mL), with or without selected inhibitors [SB203580 (SB), Bay 11-7082 (Bay), Sulfasalazine (Sul)] for 30 min. The cells were homogenized in RIPA buffer containing a cocktail of proteinase and phosphatase inhibitors. Protein samples were separated on a SDS-PAGE gradient gel (4–12% Bis-Tris protein gel; Thermo Fisher Scientific) and transferred to PVDF membranes. The blots were blocked with 5% BSA for 1 h and incubated with phospho-p38 antibody (1:1,000; Cell Signaling Technology) and phospho-NF-κB p65 antibody (1:1,000; Cell Signaling Technology) overnight at 4°C. The blots were then incubated in HRP-conjugated secondary antibody (1:3,000) for 1 h at room temperature, developed in ECL solution (Thermo Fisher Scientific) for 1 min, and exposed by G-Box imager. The blots were then incubated in stripping buffer (Thermo Fisher Scientific) at 37°C for 15 min and reprobing with IκBα antibody (1:1,000; Cell Signaling Technology) or p38 antibody (1:1,000; Cell Signaling Technology) or NF-κB p65 antibody (1:1,000; Cell Signaling Technology) or GAPDH antibody (1:3,000; Cell Signaling Technology).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!